Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.55 |
| ▸ | EYA2 | O00167 | 1/20 | 0.55 |
| ▸ | APP | P05067 | 1/20 | 0.55 |
| ▸ | ACE | P12821 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL120640 | 0.97 | — | — | |
| SCHEMBL14890359 | 0.97 | TDP1 (0.58) | TDP1EYA2APPACEBLM | |
| Acetic Acid SCHEMBL28354875 | 0.95 | TDP1 (0.50) | TDP1EYA2APPACEBLM | |
| SCHEMBL9305268 | 0.94 | TDP1 (0.55) | TDP1EYA2APPACEBLM | |
| Potassium SCHEMBL3894343 | 0.94 | TDP1 (0.55) | TDP1EYA2APPACEBLM | |
| Bromide SCHEMBL6981455 | 0.94 | TDP1 (0.55) | TDP1EYA2APPACEBLM | |
| SCHEMBL9306714 | 0.94 | TDP1 (0.55) | TDP1EYA2APPACEBLM | |
| SCHEMBL9306621 | 0.94 | TDP1 (0.55) | TDP1EYA2APPACEBLM | |
| SCHEMBL9304702 | 0.94 | TDP1 (0.55) | TDP1EYA2APPACEBLM | |
| SCHEMBL9304543 | 0.94 | TDP1 (0.55) | TDP1EYA2APPACEBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0846737-B1 | Emulsion ink for stencil printing | RISO KAGAKU CORP (JP) | 2002-11-06 | — | — | EP | claimed |
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | SHOFU INC. (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20250064686-A1 | DENTAL CURABLE COMPOSITION CONTAINING ULTRAVIOLET ABSORBER | SHOFU INC (JP) | 2025-02-27 | — | — | US | disclosed |
| EP-4473954-A1 | DENTAL CURABLE COMPOSITION CONTAINING ULTRAVIOLET ABSORBER | Shofu Inc. (JP) | 2024-12-11 | — | — | EP | disclosed |
| US-12064493-B2 | Dental photocurable composition having excellent storage stability | SHOFU INC. (JP) | 2024-08-20 | — | — | US | disclosed |
| US-12011490-B2 | Dental photocurable composition excellent in operability and storage stability | SHOFU INC. (JP) | 2024-06-18 | — | — | US | disclosed |
| EP-3888616-B1 | DENTAL PHOTOCURABLE COMPOSITION EXCELLENT IN COLOR TONE SELECTIVITY | SHOFU INC (JP) | 2024-05-15 | — | — | EP | disclosed |
| WO-2023202604-A1 | ANTIVIRAL NUCLEOSIDE ANALOGUE, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 中国科学院上海药物研究所 | 2023-10-26 | — | — | WO | disclosed |
| US-11696874-B2 | Dental photocurable composition excellent in color tone selectivity | SHOFU INC. (JP) | 2023-07-11 | — | — | US | disclosed |
| US-20230127080-A1 | NOVEL CATIONIC LIPID HAVING CYSTINE SKELETON | NOF CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20020066671-A1 | Seed layer deposition | SHIPLEY COMPANY, L.L.C. (US) | 2002-06-06 | — | — | US | disclosed |
| EP-1201786-A2 | Seed layer deposition | Shipley Company LLC (US) | 2002-05-02 | — | — | EP | disclosed |
| EP-1201787-A2 | Plating catalysts | Shipley Company LLC (US) | 2002-05-02 | — | — | EP | disclosed |
| US-5948151-A | Emulsion ink for stencil printing | RISO KAGAKU CORPORATION (JP) | 1999-09-07 | — | — | US | disclosed |
| US-5935745-A | Image forming method, image forming medium and image receiving medium | FUJI XEROX CO., LTD. (JP) | 1999-08-10 | — | — | US | disclosed |
| EP-0846737-A1 | Emulsion ink for stencil printing | RISO KAGAKU CORPORATION (JP) | 1998-06-10 | — | — | EP | disclosed |
| WO-1995000536-A1 | PEPTIDE COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-01-05 | — | — | WO | disclosed |
| EP-0331736-B1 | PRODUCTION OF THIN-FILM ELECTROLUMINESCENT DEVICE | KABUSHIKI KAISHA KOMATSU SEISAKUSHO (JP) | 1993-10-13 | — | — | EP | disclosed |
| US-5164225-A | METHOD OF FABRICATING THIN-FILM EL DEVICE | KABUSHIKI KAISHA KOMATSU SEISAKUSHI (JP) | 1992-11-17 | — | — | US | disclosed |
| EP-0331736-A1 | PRODUCTION OF THIN-FILM ELECTROLUMINESCENT DEVICE | KABUSHIKI KAISHA KOMATSU SEISAKUSHO (JP) | 1989-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | BOLA2; BOLA2B, LBR, COL2A1 | TDP1 1382/4885EYA2 3696/4885APP 4189/4885 |
| US-12064493-B2 | Dental photocurable composition having excellent storage stability | H1-0, H1-2, H1-4 | TDP1 587/4885EYA2 1911/4885APP 2459/4885 |
| US-12011490-B2 | Dental photocurable composition excellent in operability and storage stability | H1-0, CCND1, CCNT1 | TDP1 903/4885EYA2 2638/4885APP 3270/4885 |
| US-20230127080-A1 | NOVEL CATIONIC LIPID HAVING CYSTINE SKELETON | SGMS1, SLC7A11, SGMS2 | TDP1 3199/4885EYA2 4325/4885APP 3202/4885 |
| US-20250064686-A1 | DENTAL CURABLE COMPOSITION CONTAINING ULTRAVIOLET ABSORBER | ERCC1, DSC1, CRYAA | TDP1 798/4885EYA2 4275/4885APP 2167/4885 |
| US-11696874-B2 | Dental photocurable composition excellent in color tone selectivity | HBG1, MARK1, KATNA1 | TDP1 910/4885EYA2 4032/4885APP 3038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.